ENDOLOGIX INC's ticker is and the CUSIP is 29266SAA4. A total of 18 filers reported holding ENDOLOGIX INC in Q2 2014. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $3,814,000 | -34.3% | 4,000,000 | -33.3% | 0.06% | -26.2% |
| Q1 2017 | $5,808,000 | +7.1% | 6,000,000 | 0.0% | 0.08% | +5.0% |
| Q4 2016 | $5,423,000 | -37.7% | 6,000,000 | -33.3% | 0.08% | -29.2% |
| Q3 2016 | $8,711,000 | +280.1% | 9,000,000 | +267.9% | 0.11% | +175.6% |
| Q2 2016 | $2,292,000 | -23.3% | 2,446,000 | -18.5% | 0.04% | -21.2% |
| Q2 2014 | $2,989,000 | -55.2% | 3,000,000 | -57.1% | 0.05% | -58.7% |
| Q1 2014 | $6,670,000 | – | 7,000,000 | – | 0.13% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 51,117,000 | $46,140,000 | 1.90% |
| PFM Health Sciences, LP | 6,445,000 | $5,809,000 | 0.16% |
| Partner Investment Management, L.P. | 84,000 | $76,000 | 0.10% |
| ADVENT CAPITAL MANAGEMENT /DE/ | 5,562,000 | $5,013,000 | 0.09% |
| OAKTREE CAPITAL MANAGEMENT LP | 6,000,000 | $5,423,000 | 0.08% |
| PALISADE CAPITAL MANAGEMENT, LP | 1,095,000 | $1,004,000 | 0.04% |
| ACUTA CAPITAL PARTNERS, LLC | 96,000 | $86,000 | 0.03% |
| UBS OCONNOR LLC | 1,500,000 | $1,352,000,000 | 0.03% |
| AMUNDI ASSET MANAGEMENT US, INC. | 7,305,000 | $6,557,000 | 0.02% |
| Citadel Advisors | 6,230,000 | $5,624,000 | 0.01% |